Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -66.661% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCc2cccc(C(F)(F)F)c2)N(C)C31
b O=C(NCc1ccccc1Cl)C(=O)NCC1OCCN1S(=O)(=O)c1ccc(F)cc1
c Cc1ccc(OCC(=O)c2cc(C)n(C)c2C)c([N+](=O)[O-])n1
d COc1cc(OC)cc(C(=O)OC/C(O)=C(\C#N)c2nc3ccccc3[nH]2)c1
Answer: a. Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCc2cccc(C(F)(F)F)c2)N(C)C31
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCc2cccc(C(F)(F)F)c2)N(C)C31
Cc1cc2nc3n(c2cc1C)CC1CC(C(=O)NCc2cccc(C(F)(F)F)c2)N(C)C31
4,5,11-trimethyl-N-[[3-(trifluoromethyl)phenyl]methyl]-1,8,11-triazatetracyclo[7.6.0.02,7.010,14]pentadeca-2(7),3,5,8-tetraene-12-carboxamide